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Abstract
3,4-Methylenedioxymethamphetamine (MDMA; ecstasy) is known to produce euphoric states, but may also cause adverse
consequences in humans, such as hyperthermia and neurocognitive deficits. Although MDMA consumption has been
associated with visual problems, the effects of this recreational drug in retinal physiology have not been addressed hitherto.
In this work, we evaluated the effect of a single MDMA administration in the rat electroretinogram (ERG). Wistar rats were
administered MDMA (15 mg/kg) or saline and ERGs were recorded before (Baseline ERG), and 3 h, 24 h, and 7 days after
treatment. A high temperature (HT) saline-treated control group was also included. Overall, significantly augmented and
shorter latency ERG responses were found in MDMA and HT groups 3 h after treatment when compared to Baseline.
Twenty-four hours after treatment some of the alterations found at 3 h, mainly characterized by shorter latency, tended to
return to Baseline values. However, MDMA-treated animals still presented increased scotopic a-wave and b-wave
amplitudes compared to Baseline ERGs, which were independent of temperature elevation though the latter might underlie
the acute ERG alterations observed 3 h after MDMA administration. Seven days after MDMA administration recovery from
these effects had occurred. The effects seem to stem from specific changes observed at the a-wave level, which indicates
that MDMA affects subacutely (at 24 h) retinal physiology at the outer retinal (photoreceptor/bipolar) layers. In conclusion,
we have found direct evidence that MDMA causes subacute enhancement of the outer retinal responses (most prominent in
the a-wave), though ERG alterations resume within one week. These changes in photoreceptor/bipolar cell physiology may
have implications for the understanding of the subacute visual manifestations induced by MDMA in humans.
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Introduction
3,4-methylenedioxymethamphetamine (MDMA; ecstasy) is a
recreational drug often consumed at ‘‘rave’’ parties. It is a
serotonergic agent with neurotoxic potential [1,2]. Although the
death rate caused by ecstasy in humans is relatively low compared
to other drugs of abuse, it has been associated with potential fatal
consequences, including hyperthermia, rhabdomyolysis, hepato-
toxicity, cardiotoxicity, and acute renal failure [3,4,5]. It has been
also associated with significant deficits in neurocognitive function,
mainly verbal memory [1,6].
Characteristic psychotropic effects are thought to be caused by
enhanced serotonin (5-hydroxytryptamine, 5-HT) release, al-
though some effects may also involve norepinephrine and
dopamine (DA) [1,7]. In laboratory animals, MDMA administra-
tion is known to induce an acute and rapid release of both 5-HT
[8] and DA [9] from serotonergic and dopaminergic nerve
endings. The acute release can be followed by long-term
neurotoxic transmitter depletion, mainly 5-HT, in some brain
regions, as experimentally observed in the rat [10,11] and monkey
[12]. However, it is not yet clear whether these MDMA neurotoxic
effects underlie overt cognitive deficits. This is still a matter of
controversy and further research is needed [13].
MDMA induces programmed cell death, with a significant
increase of apoptosis markers in the amygdala and hippocampus
[14], and also in cerebellar granule [15] and cortical [16] neuronal
cultures. Unlike the numerous available brain research reports,
there are scarce studies addressing the effects of MDMA in the
retina and vision. Changes in light perception were demonstrated
in humans after the administration of repeated doses of MDMA
[17,18,19]. Moreover, the drug has been found in human vitreous
humor after MDMA ingestion [20,21], and vitreal MDMA
quantification was proposed as a reliable way to measure the
MDMA concentration for toxicological analysis [22]. Also, there
are a few clinical case reports of ocular problems after MDMA
ingestion [23,24]. There is only one study evaluating the effect of
MDMA administration in the rat retina [25]. The authors found
that the number of TUNEL-positive nuclei increased significantly
in rat retinas after one week of daily MDMA administration. We
also showed that exposure of cultured retinal neural cells to
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studies suggest that MDMA can affect retinal physiology in
addition to its harmful effects to the brain.
Taking the scarcity of direct physiological studies into account,
we evaluated potential alterations in the rat retinal light responses
induced by a single peripheral administration of MDMA. We used
electroretinography, which is a technique that measures global
retinal population responses which tend to be dominated by
particular groups of retinal layers allowing pathophysiological
interpretation [27,28,29]. We found MDMA-induced ERG
changes that were independent of elevated temperature, in
particular for the outer retinal layers. The MDMA-induced effects
were present 24 h after drug administration though they resume
after 7 days. These findings suggest a direct retinal effect of
MDMA that may have implications for the understanding of
visual perceptual effects induced by this drug.
Methods
Animals and drug administration
All procedures involving animals were in accordance with the
Association for Research in Vision and Ophthalmology (ARVO)
statement for vision and ophthalmic research, and were approved
by our Institutional Ethics Committee (Comissa ˜o de E ´tica da
Faculdade de Medicina da Universidade de Coimbra). Approval ID:
FMUC/12/09. Ethics Committee for Animal Experiments:
Manuel Amaro de Matos Santos Rosa, MD/PhD; Paulo de
Carvalho Pereira, PhD; Anto ´nio Francisco Rosa Gomes Ambro ´-
sio, PhD; Fla ´vio Nelson Fernandes Reis, PhD (Ethics Statement).
Male Wistar rats aged 8 weeks were maintained at 2261uCo na
12 h light/12 h dark cycle, with access to water and food ad
libitum. In the first study, 30 animals were divided into three
groups: Control (n=10), high temperature (HT, n=8), and
MDMA (n=12). In a second study (7 days ERGs) 24 animals were
divided into two groups: Control (n=12) and MDMA (n=12).
The rationale for the high temperature group is to mimic the
temperature elevation detected in MDMA-treated animals, since
body temperature affects ERG recordings [30]. MDMA-treated
animals received one single intraperitoneal (i.p.) injection of
racemic MDMA (15 mg/kg). Control and HT animals received
one single i.p. injection of saline (0.9% NaCl). I.p. injections were
performed under dim red light.
ERG recordings
ERGs were recorded after overnight dark adaptation. In the
first study, ERGs were recorded 24 h before treatment (i.p.
injection), 3 h after treatment; and 24 h after treatment. In the
second study, ERGs were recorded 7 days before, and 7 days after
treatment (i.p. injection). In both studies, the ERGs performed
before treatment were considered Baseline ERGs. The animals
were anesthetized by intramuscular injection of ketamine
hydrochloride (50 mg/kg) and xylazine (10 mg/kg) and the pupil
fully dilated with topical tropicamide (1%) under dim red light
illumination. The body temperature was maintained with a
heating pad set to 37uC during the procedure, except for the
high temperature animals at the 3 h time point in the first study.
In that case, the heating pad was set to 45uC during 10 min before
ERG recording to induce an elevation in the animal body
temperature (37.660.5uC) to mimic the temperature found in
animals administered MDMA at the same time point (37.460.6uC
in the MDMA group compared to 35.360.8uC in the Control
group). Using a Ganzfeld stimulator, series of white light flashes
ranging from 0.0095 to 9.49 cd-s/m
2 were applied under scotopic
and photopic conditions (in the latter case, after light adaptation to
a white background (25 cd/m
2). A photopic flicker test was also
performed where white bright flashes (3.00 and 9.49 cd-s/m
2)
were delivered ten times at 6.3 Hz. ERGs were recorded with a
corneal gold wire electrode, a reference electrode at the head, and
a ground electrode in the tail. A band width of 1–300 Hz and
sampling rate of 3.4 kHz (0.65 kHz for flicker test) were used for
acquisition (Roland Consult GmbH, Brandenburg, Germany).
OFF-line digital filters were applied on the b-wave (high frequency
cut-off of 50 Hz) and oscillatory potentials (low frequency cut-off
of 60 Hz for scotopic ERGs and 55 Hz for photopic ERGs) with
the RETIport software (Roland Consult GmbH, Brandenburg,
Germany).
Statistical analysis
These experiments were designed to compare temporal effects
across treatments within subjects. We have therefore applied, in
the first study, mixed between-within subjects (repeated measures)
ANOVA. Effects were tested along time (Baseline, 3 h, 24 h) as
within-subject factors, and the type of pharmacological manipu-
lation (Control, HT, MDMA) was the between-subject (group)
factor. An additional factor was the interaction term between time
and group (Wilks’ lambda test). This analysis was followed by post
hoc paired t test. In the second study paired t tests were used to
compare temporal effects across treatments within subjects. P
values at a stringent criterion of less than 0.01 were taken as
significant. In figures, temporal data are normalized to Baseline to
better emphasize within subject effects. All values are presented as
mean 6 SEM.
Results
To evaluate the potential effects of MDMA on retinal
physiology, scotopic and photopic ERGs were recorded in animals
administered with MDMA (15 mg/kg; single administration).
Since MDMA induces acute hyperthermia, which affects ERG
responses, we included a group of animals (saline-treated) with
increased body temperature (high temperature; HT) only at 3 h
time point, in the first study. In the second study, only Control and
MDMA groups were included in order to evaluate the effect of
MDMA (15 mg/kg; single administration) 7 days after i.p.
injection.
Differential effects of MDMA and HT on ERG responses
under scotopic conditions
a-wave and b-wave after 3 h and 24 h. ERGs were
recorded 24 h before (Baseline ERG), and 3 h and 24 h after
saline or MDMA i.p. injection (Fig. 1A), in the first study. In the
second study, ERGs were performed 7 days before (Baseline ERG)
and 7 days after i.p. injection (Fig. 1B). Waveforms were elicited by
flash light stimuli with intensities ranging from 0.0095 to 9.49 cd-
s/m
2.
The a-wave values were extracted from scotopic ERG
recordings elicited by six different light intensities (0.03 –
9.49 cd-s/m
2) since at 0.00095 cd-s/m
2 the a-wave was not
detected. In the first study, the ANOVA within subject analysis
indicated a significant main effect of time for amplitude
(F(2,143)=38.6; p,0.001) (Fig. 2A1) and time to peak
(F(2,143)=26.8; p,0.001) (Fig. 2A2). There was also an interaction
between time and group in both amplitude and time to peak
values (p,0.001). Post hoc analyses showed that both MDMA-
treated and HT groups had increased a-wave amplitudes
(p,0.001) and decreased time to peak values (p,0.001 for
MDMA and p,0.01 for HT groups) at the 3 h time point, when
compared to Baseline ERG, while the Control group showed no
Effects of MDMA on Retinal Physiology
PLoS ONE | www.plosone.org 2 December 2011 | Volume 6 | Issue 12 | e29583Figure 1. Effect of MDMA administration and high temperature (HT) on scotopic ERGs. Representative traces of individual scotopic ERGs
recorded 24 h before saline or MDMA i.p. injection (Baseline ERG), and 3 h and 24 h after i.p. injection (A), and also recorded 7 days before (Baseline
ERG) and 7 days after i.p. injection (B) . Waveforms were elicited by flash light stimuli with 3.0 cd-s/m
2. Each trace represents an average of three
responses. Solid vertical lines indicate the onset of flash light stimuli.
doi:10.1371/journal.pone.0029583.g001
Figure 2. Effect of MDMA and HT on the a-wave and b-wave at 3 h and 24 h. The a-wave (A) and b-wave (B) were extracted from scotopic
ERG recordings. The mean values of each Baseline ERG analyzed were subtracted to 3 h and 24 h ERG values in the same group and the obtained
delta values (D) are presented for graphical illustration. (A1,B1) Both MDMA and HT groups had increased a-wave and b-wave amplitudes at 3 h time
point, while no differences were found in the Control group when responses were compared to the Baseline ERG. At 24 h time point only MDMA
group presented increased a-wave and b-wave amplitude values when compared to Baseline ERG. (A2,B 2) Both MDMA and HT groups presented
decreased time to peak values at 3 h time point when compared to Baseline ERG in both the a-wave and b-wave, while no significant differences
were found at 24 h time point compared to Baseline ERG in all groups. *** p,0.001 MDMA group compared to Baseline ERG; ++ p,0.01, +++
p,0.001 HT group compared to Baseline ERG. The data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0029583.g002
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(fast onset) photic response of photoreceptors after MDMA
administration, mainly due to body temperature elevation, since
HT group had a similar behavior. Importantly, at the 24 h time
point, only the MDMA-treated group showed increased amplitude
values when compared to Baseline ERG (p,0.001), while in both
Control and HT groups the a-wave amplitude values returned to
Baseline levels (Fig 2A1). This shows that a factor other than
temperature might be associated with changes induced by MDMA
in the a-wave 24 h after drug administration. Time to peak values
at 24 h time point showed no difference when compared to
Baseline ERG for all groups.
The b-wave values were extracted from scotopic ERG
recordings elicited by seven different light intensities (0.0095–
9.49 cd-s/m
2). The ANOVA repeated measures (within subjects)
analysis indicated a main effect of time for amplitude
(F(2,167)=62.3; p,0.001) (Fig. 2B1) and time to peak
(F(2,167)=29.2; p,0.001) (Fig. 2B2), and a significant interaction
between time and group for both amplitude and time to peak
values (p,0.001). Similarly to the a-wave, results of the post hoc
analysis for the b-wave showed that both MDMA and HT groups
had increased amplitudes and decreased time to peak values at the
3 h time point when compared to Baseline ERG (p,0.001), while
in Control group no differences were observed. Remarkably, and
as observed for the a-wave, 24 h after treatment, only the MDMA
group presented increased amplitude values when compared to
Baseline (p,0.001), while in both Control and HT groups the b-
wave amplitude remained unchanged (Fig 2B1). Time to peak
values at 24 h time point presented no differences when compared
to Baseline ERG for all groups (Fig 2B2). Together these results
suggest that temperature elevation causes the augmented and
‘‘accelerated’’ (fast onset) b-wave 3 h after MDMA administration,
since a similar behavior was detected in the HT group. However,
and in agreement with the results obtained concerning the a-wave,
they show that a factor other than temperature is implicated in
MDMA-induced increases in the b-wave amplitude observed 24 h
after MDMA administration.
Regarding the b/a amplitude ratio, ANOVA mixed between
and within subjects analysis indicated that there were no
significant effects (data not shown), suggesting that the effects
observed at the b-wave level result from alterations at the a-wave
level (no amplification in effect size).
a-wave and b-wave after 7 days. In the second study,
ERGs were recorded 7 days before (Baseline ERG) and 7 days
after i.p. injection. The a-wave (Fig 3A) and b-wave (Fig 3B)
amplitude and time to peak values were extracted as in the first
study. The paired-samples t test showed that there were no
differences in the a-wave both in Control and MDMA groups at 7
days when compared to Baseline ERG, either in the a-wave
amplitude (Fig 3A1) or in the a-wave time to peak values (Fig 3A2).
The b-wave amplitude showed similar behavior to the a-wave with
no significant differences in both Control and MDMA groups
(Fig 3B1). However, regarding time to peak, the MDMA group
presented increased values at 7 days when compared to Baseline
ERG (p,0.001), though the Control group showed a similar trend
(Fig 3B2). These results suggest that the augmented amplitudes of
the a-wave and b-wave induced by MDMA administration at 24 h
were not present 7 days after i.p. injection.
Figure 3. Effect of MDMA on the a-wave and b-wave at 7 days. The a-wave (A) and b-wave (B) were extracted from scotopic ERG recordings.
The mean values of each Baseline ERG analyzed were subtracted to 7 days ERG values in the same group and the obtained delta values (D) are
presented for graphical illustration. (A1,B 1) No differences were found both in the Control and MDMA group in the a-wave and b-wave amplitudes 7
days after i.p. injection when compared to Baseline ERG. (A2) No differences were found both in Control and MDMA groups in the a-wave time to
peak values. (B2) At 7 days, MDMA group presented increased time to peak values in the b-wave, when compared to Baseline ERG, though the
Control group show a similar trend (p=0.015). *** p,0.001 MDMA group compared to Baseline ERG. The data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0029583.g003
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potential waveforms (OPs), OP1, OP2, OP3, and OP4, were
extracted from scotopic ERGs elicited by five different light
intensities (0.095 – 9.49 cd-s/m
2). For the OP amplitudes the
ANOVA repeated measures (within subjects) analysis indicated
that although there is a main effect of time for all OPs: OP1
(F(2,118)=45.4; p,0.001); OP2 (F(2,119)=32.4; p,0.001); OP3
(F(2,119)=35.5; p,0.001); and OP4 (F(2,119)=13.8; p,0.001),
there is a significant interaction between time and group only
for the OP3 (p,0.001) (Fig. 4A1), and OP4 (p,0.001) (data
shown only for the OP3 component), though OP2 showed a
marginally significant interaction effect (p=0.047). Post hoc
analysis showed that both MDMA and HT groups presented
increased OP3 amplitude at 3 h (p,0.001) and 24 h (p,0.001
for MDMA and p,0.01 for HT) time points when compared to
Baseline ERG (Fig 4A1). This result suggests the existence of a
p r o l o n g e de f f e c tc a u s e db ye l e v a t e dt e m p e r a t u r ei nM D M A -
induced OP amplification 3 h after drug administration.
Contrarily to the observations concerning the a-wave and b-
wave, in this particular case, at 24 h time point, it was not
possible to discard a temperature contribution since the HT
animals also showed increased amplitudes when compared to
Baseline ERG. The results obtained for the Sum of OP
amplitudes corroborate the hypothesis that no genuine effect
of MDMA is found in this parameter since, at 24 h time point,
all groups presented increased values when compared to
Baseline ERG (p,0.001 for MDMA and HT groups; p,0.01
for Control group; Fig 4B).
Time to peak values followed the pattern observed for the a-
wave and b-wave (Fig. 4A2). ANOVA repeated measures analysis
indicated a main effect of time for all OPs: OP1 (F(2,118)=148;
p,0.001); OP2 (F(2,119)=170; p,0.001); OP3 (F(2,119)=142;
p,0.001); and OP4 (F(2,119)=150; p,0.001). There was also a
significant interaction between time and group, for OP1, OP2,
OP3, and OP4 (p,0.001). Post hoc analysis confirmed a similar
behavior as for the a-wave and b-wave, in which both MDMA and
HT groups presented decreased time to peak values at 3 h time
point (p,0.001), while in the Control group no changes were
detected. In addition, no differences were found for all OPs 24 h
after treatment, when compared to Baseline ERG (Fig 4A2). This
result confirms that the temperature elevation is implicated in the
‘‘accelerated’’ (fast onset) response found in MDMA-treated
animals, as the behavior was identical to that found in HT
animals.
Oscillatory potentials at 7 days. Four oscillatory potential
waveforms, OP1, OP2, OP3, and OP4, were extracted from
scotopic ERGs elicited by five different light intensities (0.095 –
9.49 cd-s/m
2). Concerning the 7 days time point, paired-samples t
test showed that there were no significant differences in OP
amplitudes (Fig 5A1) and in the Sum of OP amplitudes (Fig 5B)
Figure 4. Effect of MDMA and HT on the scotopic OPs at 3 h and 24 h. Four oscillatory potentials (OPs), OP1, OP2, OP3, and OP4, were
extracted from scotopic ERGs. (A) Only the effect on the OP3 amplitude and time to peak is shown. (A1) Both MDMA and HT groups had increased
OP3 amplitudes at 3 h and 24 h time points when compared to Baseline ERG, while no differences were found in the Control group. (A2) Time to
peak values showed the same behavior for all OPs, in which both MDMA and HT groups presented decreased time to peak values at 3 h time point
when compared to Baseline ERG. At 24 h time point similar values were obtained in all groups. (B) Both MDMA and HT groups had increased Sum of
OP amplitudes at 3 h and 24 h time points when compared to Baseline ERG. However, at 24 h time point, the Control group also presented increased
amplitudes when compared to Baseline ERG. *** p,0.001 MDMA group compared to Baseline ERG; ++ p,0.01, +++ p,0.001 HT group compared to
Baseline ERG; ## p,0.01 Control group compared to Baseline ERG. The data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0029583.g004
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peak values, there was a significant increase in both Control and
MDMA groups at 7 days when compared to Baseline ERG
(p,0.001, Fig 5A2). This result is in accordance with the increased
time to peak values found in the b-wave (Fig 3B2) and suggests a
slightly delayed response in both groups at 7 days when compared
to Baseline ERG.
Differential effects of MDMA and HT on ERG responses
during photopic adaptation
ERGs were also recorded during light adaptation to a white
background light (25 cd/m
2), 24 h before saline or MDMA i.p.
injection, and 3 h and 24 h after i.p. injection in the first study
(Fig. 6A). In the second study, ERGs were recorded 7 days before
i.p. injection (Baseline ERG) and 7 days after i.p. injection (Fig 6B).
Figure 5. Effect of MDMA and HT on the scotopic OPs at 7 days. Four oscillatory potentials (OPs), OP1, OP2, OP3, and OP4, were extracted
from scotopic ERGs. (A) Only the effect on the OP3 amplitude and time to peak is shown. (A1) No differences were found both in Control and MDMA
groups at 7 days when compared to Baseline ERG. (A2) Time to peak values showed the same behavior for all OPs, in which both Control and MDMA
groups presented increased time to peak values at 7 days when compared to Baseline ERG. (B) No differences were found both in Control and MDMA
groups in the Sum of OP amplitudes at 7 days when compared to Baseline ERG. *** p,0.001 MDMA group compared to Baseline ERG; ### p,0.001
Control group compared to Baseline ERG. The data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0029583.g005
Figure 6. Effects of MDMA and HT on ERG during light adaptation. Example of individual ERGs recorded during light adaptation to a white
background light (25 cd/m
2), 24 h before saline or MDMA i.p. injection (Baseline ERG), and 3 h and 24 h after i.p. injection (A), and also recorded 7
days before (Baseline ERG) and 7 days after i.p. injection (B). ERGs were elicited by bright light flashes with an intensity of 9.49 cd-s/m
2. Each trace
represents an average of three responses. ERGs were recorded at the onset (0 min) and at 2, 4, 8, and 16 min of light adaptation. In this figure only
the onset (0 min) is presented. Solid vertical line indicates the onset of flash light stimulus.
doi:10.1371/journal.pone.0029583.g006
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9.49 cd-s/m
2 and were recorded at the onset (0 min) and at 2, 4,
8, and 16 min of light adaptation. For the b-wave amplitude
values, the ANOVA repeated measures analysis indicated a main
effect of time (F(2,116)=8.54; p,0.001) and a marginally significant
interaction between time and group (p=0.013) (Fig. 7A1). The
post hoc analyses showed that only the MDMA group had
increased b-wave amplitude values at 3 h (p,0.01) and 24 h
(p,0.001). As the MDMA group, the HT group presented a
similar trend to increase the b-wave amplitude at 3 h (p=0.044),
but not at 24 h time point, when compared to Baseline ERG
(Fig 7A1). In the second study, however, the paired-samples t test
found no significant differences in both Control and MDMA
group at 7 days, when compared to Baseline ERG (Fig 7A2),
suggesting that the increased b-wave amplitude induced by
MDMA at 24 h is no longer present at 7 days. Regarding time
to peak values, ANOVA repeated measures analysis indicated a
main effect of time (F(2,116)=7.1; p,0.01) and a significant
interaction between time and group (p,0.001). However, only the
HT group reached statistically significant decreased values at 3 h
time point when compared to Baseline ERG, while at 24 h time
point there were no differences for all groups. Also, in the second
study there were no significant differences in time to peak values at
7 days when compared to Baseline ERG (data not shown).
MDMA effects on ERG responses following photopic
adaptation
In the period that followed photopic adaptation, and regarding
the b-wave amplitude, no significant interaction between time and
group was found. Although at 24 h time point only the MDMA
group presented a significant increase in the b-wave amplitude,
when compared to Baseline ERG (p,0.01) (Fig 7B1), a similar
trend was found in all groups at 3 h. However, the absence of an
interaction effect in repeated measures analysis renders this effect
questionable. In the second study, no significant differences were
found in the b-wave amplitude in both Control and MDMA
groups (Fig 7B2).
ANOVA repeated measures analysis indicated a main effect of
time (F(2,47)=26.4; p,0.001) and a significant interaction between
time and group for photopic b-wave time to peak values (p,0.001,
data not shown). Data followed the same behavior of scotopic
ERGs (paired t test analysis), in which both MDMA and HT
groups presented decreased time to peak values at the 3 h time
point (p,0.01 for MDMA, p,0.001 for HT), but no significant
differences were found at 24 h time point when compared to
Baseline ERG. This suggests that MDMA specific effects are not
present. In the second study, no significant differences were found
in time to peak values at 7 days when compared to Baseline ERG
(data not shown).
Figure 7. Effects of MDMA and HT on the photopic b-wave amplitude. (A) b-wave amplitude during light adaptation to a white background
light (25 cd/m
2). ERGs were recorded at the onset (0 min) and at 2, 4, 8, and 16 min of light adaptation. (B) Photopic b-wave (after light adaptation).
ERGs were elicited by white bright flashes (3.00 and 9.49 cd-s/m
2). (A1) Only the MDMA group had significantly increased b-wave amplitude during
light adaptation at 3 h, when compared to Baseline ERG, though the HT group showed the same trend as the MDMA group (p=0.044). At 24 h time
point only the MDMA group presented increased b-wave amplitude when compared to Baseline ERG. (A2) At 7 days time point no differences were
found in both Control and MDMA groups when compared to Baseline ERG. (B1) After light adaptation, increased photopic b-wave amplitude was
found in Control group at 3 h when compared to Baseline ERG, though HT (p=0,089) and MDMA (p=0,017) groups may show similar behavior. At
24 h time point only MDMA group presented increased photopic b-wave amplitude when compared to Baseline ERG. (B2) No differences were found
at 7 days time point when compared to Baseline ERG. ** p,0.01, *** p,0.001 MDMA compared to Baseline ERG; ## p,0.01 Control group
compared to Baseline ERG. The data are presented as mean 6 SEM.
doi:10.1371/journal.pone.0029583.g007
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photopic OP amplitudes in which no interaction between time and
group was found. Nevertheless, in the OP time to peak values the
ANOVA repeated measures analysis indicated a main effect of
time for all OPs detected: F(2,17)=30.7; p,0.001 for OP2;
F(2,17)=40; p,0.001 for OP3; and F(2,17)=18; p,0.001 for
OP4; as well as a significant interaction between time and group
(p,0.001 for the OP2, OP3, and OP4; concerning OP1 no
waveform was detected). Post hoc paired t test analysis showed that
both HT and MDMA groups had decreased time to peak values at
3 h time point when compared to Baseline ERG (for all OPs
detected). In the second study, no significant differences were
found in the OP amplitude and time to peak values in both
Control and MDMA groups at 7 days when compared to Baseline
ERG (data not shown).
Photopic flicker ERG results were analyzed using the Fast
Fourier Transform (FFT). We considered the first two harmonics,
which are the more representative of the original waveform. The
corresponding values for the harmonic amplitude and phase
correlate with ERG amplitude and time to peak, respectively. In
the first study, the results from the photopic flicker test indicated
that there was no significant interaction between time and group
for the 1
st and 2
nd harmonic amplitude values of FFT. However, in
the 1
st and 2
nd harmonic phase values of FFT, in a similar way to
the time to peak values of scotopic and photopic ERG, the
ANOVA repeated measures analysis indicated a main effect of
time for the 1
st (F(2,47)=60.3; p,0.001) and the 2
nd (F(2,47)=58.1;
p,0.001) harmonic components, as well as a significant
interaction between time and group for the 1
st (p,0.001) and
2
nd (p,0.001) harmonic components. Moreover, post hoc paired t
test analysis indicated that both MDMA and HT groups presented
decreased phase values at 3 h time point (p,0.001), but no
significant differences were found at 24 h time point when
compared to Baseline ERG. In the second study no significant
differences were observed in the photopic flicker ERG in both
Control and MDMA groups at 7 days when compared to Baseline
ERG (data not shown).
Discussion
In this study, we have found direct evidence that MDMA causes
acute and subacute enhancement of outer retinal responses. Since
MDMA induces an acute increase in body temperature, light
responses are consequently increased and accelerated. The increase
in light responses may persist 24 h after drug administration. This
effect was most prominent in the scotopic a- and b-waveforms
(corresponding to photoreceptor/bipolar cell circuits), and could
not be explained by temperature elevation (present only 3 h after
treatment). Regarding photopic ERG, no interaction was found
between time and group for some major parameters, namely the b-
wave amplitude and photopic flicker. This result suggests that some
MDMA specific effects are more subtle when the retina is light
adapted. This also suggests that cone-based pathways are relatively
less sensitive to subacute effects of MDMA than rod circuits. One
week after MDMA administration the ERG alterations observed at
24 hwere nolongerpresent.Noincreasedresponses,eitherinthea-
wave or in the b-wave, were found at 7 days. Also, in photopic
responses, contrarily to the effect found at 24 h, no increased b-
wave amplitude during light adaptation was observed 7 days after
MDMA administration when compared to Baseline. Together,
these results suggest that MDMA induces subacute ERG alter-
ations, and a recovery occurs within one week of abstinence.
To our knowledge, this is the first study addressing the effects of
MDMA administration on in vivo retinal neurophysiology, assessed
by means of the rat ERG. The ERG changes found 3 h after
MDMA administration can be mainly attributed to the increase in
body temperature induced by MDMA, a well known effect of this
drug, since the high temperature (HT) control animals had similar
responses to those found in the MDMA group for the majority of
the analyzed parameters, at this particular time point. These
temperature-induced changes in ERG are consistent with previous
studies in rat [31] and mouse [30]. Since the elevation in body
temperature increased a-wave amplitude and decreased a-wave
time to peak, it is likely that these changes reflect alterations in the
rod photoresponses that are known to be temperature-dependent
being higher and ‘‘accelerated’’ (fast onset) at higher temperatures
in mammals [32]. Similar temperature-induced changes are likely
to occur also in cone photoreceptors [33]. The augmented and
accelerated light responses, due to body temperature increase, are
likely to acutely affect visual perception in humans after MDMA
ingestion in nightclubs or ‘‘rave’’ parties.
At the 24 h time point, the body temperature in animals from
MDMA and HT groups was similar to Control group. However,
only the MDMA group presented significantly increased a-wave
amplitude, when compared to Baseline, suggesting the presence of
a genuine pharmacological effect. It is important to note that the
effect in the b-wave amplitude is likely to reside in the a-wave
generating mechanisms, the photoreceptors, since no significant
differences were found in the b/a ratio at both time points (no
evidence for effect amplification). However, we cannot exclude the
possibility that post-photoreceptor components are involved, since
the a-wave peak amplitude has also been shown to reflect post-
photoreceptor contributions [34].
Regarding the increased a-wave and b-wave amplitudes found
24 h after MDMA administration, we can attribute this augment-
ed light response to a direct effect of MDMA since HT group show
recovery from the values obtained at 3 h time point. For the OPs
we cannot discard a contribution of temperature elevation in
MDMA group since HT group also presented increased
amplitudes.
MDMA administration induces acute and long-term disruption
of the serotonergic system, although the dopaminergic system can
be acutely affected as well [1,2]. Moreover, MDMA has been
shown to influence suprachiasmatic nucleus (SCN) circadian
rhythm [35]. Taking these evidences into account, we suggest that
the subacute alterations found in our recordings could be the result
of MDMA-induced effects directly on the retinal serotonergic
and/or dopaminergic system, or indirectly on SCN circadian
rhythm although this explanation remains a speculation at this
point.
In the mammalian retina, there is evidence for the presence of a
mechanism for active 5-HT uptake [36] and various 5-HT
receptors were identified [37]. In addition, 5-HT administered
directly in the vitreous of cat eye increased b-wave amplitude [38].
The authors suggested that perhaps increased 5-HT uptake into
GABAergic amacrine cells changes the functional properties of
these cells therefore reducing GABAergic inhibition in the retina,
and consequently increasing the light responses. Conversely, the
destruction of 5-HT accumulating amacrine cells in the rabbit
retina results in decreased b-wave amplitude, but increased OPs
[39], which is consistent with the fact that OPs have a distinct
origin from the b-wave and mainly originate from the inner retina
in relation to oscillatory patterning in ganglion cells [40,41].
However, these studies did not address whether these findings
were directly due to the lack of 5-HT.
It has been shown that MDMA can alter the ability of SCN to
phase shift in response to a photic or non-photic stimulus [35]. In
addition, single or repeated administration of MDMA to rats
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wakefulness [42,43]. Therefore, we hypothesize that in the present
study MDMA administration may induce changes in serotonergic
SCN or raphe nerve fibres, which have been shown to influence
retinal physiology, including light responses [44], thus causing the
subacutely altered ERGs observed. Furthermore, an altered SCN
circadian pattern can influence the dopamine-melatonin cycle in
the retina, which in turn, can greatly affect ERG responses
[45,46]. Indeed, DA levels in the retina are under circadian
control, peaking during the day, which means that although more
DA is released upon light stimulation, retinal DA-mediated effects
occur even in the absence of light stimulation or light adaptation
[47]. Based on these properties of DA, we hypothesize that even a
slight shift in DA circadian phase could be responsible for the
increased a-wave, due to strongly augmented rod photic responses,
observed specifically in the MDMA group at the 24h time point.
In a recent study, Vielma and colleagues found increased a-
wave, b-wave, and also OP amplitudes in rat eyes treated
intravitreally with various nitric oxide (NO) donors [48]. The
effect of NO was found under both scotopic and photopic
conditions. The authors suggested that the NO-induced increase
in S-nitrosation at photoreceptor level is responsible for ERG
signal amplification since cGMP or cAMP pathways were not
involved. Although previous studies reported reduced ERG
amplitudes and retinal citotoxicity induced by NO donors
[49,50], in this study the authors showed that the effect of NO
is dose-dependent and indeed, for higher doses, it decreases ERGs.
MDMA administration was found to be associated with increased
NOS activity and NO production [51]. Moreover, nitrosative
stress has been associated with MDMA-induced 5-HT depletion
[52]. Miranda and colleagues (2007) were able to reduce the
MDMA toxic effects in the rat retina using an antioxidant with
efficient NO and peroxynitrite scavenging capacity, CR-6 (3,4-
dihydro-6-hydroxy-7-methoxy-2,2-dimethyl-1(2H)-benzopyran)
[53]. Taking this into account, we can also speculate about the
presence of elevated NO levels or S-nitrosation in the retina 24 h
after MDMA administration. In this view, NO could also be
involved in the increased amplitudes found in MDMA-treated
animals at 3 h and 24 h.
To summarize, it was demonstrated for the first time that a
single MDMA peripheral administration to rats induces an acute
and subacute enhancement of outer retinal responses, as
demonstrated by ERG recordings, which resume within one week
of abstinence. Acute effects appear to be mostly due to the increase
in body temperature (which is a well established acute effect of
MDMA) since similar alterations were also detected in HT
animals. Both MDMA and HT groups presented similar body
temperature values (<37.5uC) at this time point. Importantly, we
also detected subacute (at 24 h time point) changes in the ERGs
induced by MDMA administration. At this time point the animal
body temperature was similar in all groups. Since the amplitude
values for the a-wave were found to be significantly increased only
in MDMA-treated animals, MDMA might induce higher rod
photoreceptor light response. However, subacute increased light
responses induced by MDMA, after single administration, were no
longer present when ERGs were recorded after one week of
MDMA abstinence. Therefore, a single administration of MDMA
might induce temporary changes on retinal physiology, which may
contribute to altered visual perception and visual acuity after
MDMA use [17,18,19]. Human MDMA users may experience
acute augmented light sensitivity due to hyperthermia, and some
visual alterations might persist in the following day.
Future studies should address whether these changes in light
responses persist after repeated MDMA administrations. Also, it
will be important to evaluate the levels of retinal NO, 5-HT, and
DA, after MDMA administration, in order to determine the
significance of possible changes in this signaling molecules to
MDMA-induced effects in light responses.
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